Artificial neural networks in pancreatic disease

British Journal of Surgery

Volumn 95, Issue 7, 2008, Pages 817-826

  Bartosch Harlid A ^a   Andersson, B ^b   Aho, U ^b   Nilsson, J ^b   Andersson, R ^b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PANCREATITIS; ARTIFICIAL NEURAL NETWORK; AUTOMATION; COMPUTER PROGRAM; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; HUMAN; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDLINE; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ACUTE DISEASE; DECISION MAKING; EARLY DIAGNOSIS; PANCREAS TUMOR; PANCREATITIS; PROGNOSIS;

ACUTE DISEASE; DECISION MAKING; EARLY DIAGNOSIS; HUMANS; NEURAL NETWORKS (COMPUTER); PANCREATIC NEOPLASMS; PANCREATITIS; PROGNOSIS;

EID: 47249158871     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6239     Document Type: Review

References (64)

1. Hofbauer B, Saluja AK, Lerch MM, Bhagat L, Bhatia M, Lee HS et al. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 1998; 275: G3S2-G362.
2. Appelros S, Borgstrom A. Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg 1999; 86: 465-470.
3. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg 1999; 86: 1302-1305.
4. Mofidi R, Madhavan KK, Garden OJ, Parks RW. An audit of the management of patients with acute pancreatitis against national standards of practice. Br J Surg 2007; 94: 844-848.
5. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet 1974; 139:69-81.
6. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I, O'Neill J et al. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis. Br J Surg 1978; 65: 337-341.
7. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. A severity of disease classification system. Crit Care Med 1985; 13:818-829.
8. Bradley EL III. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-590.
9. Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990;174:331-336.
10. Gudjonsson B. Pancreatic cancer: the need for critical reassessment. J Clin Gastroenterol 1996; 23: 2-6.
11. Cucchetti A, Vivarelli M, Heaton ND, Phillips S, Piscaglia F, Bolondi L et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 2007; 56: 253-258.
12. Hedén B, Öhlin H, Rittner R, Edenbrandt L. Acute myocardial infarction detected in the 12-lead ECG by artificial neural networks. Circulation 1997; 96: 1798-1802.
13. Carrara M, Bono A, Bartoli C, Colombo A, Lualdi M, Moglia D et al. Multispectral imaging and artificial neural network: mimicking the management decision of the clinician facing pigmented skin lesions. Phys Med Biol 2007; 52:2599-2613.
14. Papadopoulos A, Fotiadis DI, Likas A. Characterization of clustered microcalcifications in digitized mammograms using neural networks and support vector machines. Art Intellig Med 2005; 34: 141-150.
15. Selaru FM, Xu Y, Yin J, Zou T, Liu TC, Mori Y et al. Artificial neural networks distinguish among subtypes of neoplastic colorectal lesions. Gastroenterology 2002; 122: 606-613.
16. Edén P, Ritz C, Rose C, Fernö M, Peterson C. "Good old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. Eur J Cancer 2004; 40: 1837-1841.
17. Haykin S. Neural Networks: a Compressive Foundation (2nd edn). Prentice-Hall: Upper Saddle River, 1999.
18. Nilsson J. Risk Stratification in Cardiac Surgery: Algorithms and Applications. Faculty of Medicine Doctoral Dissertation Series 2005. Lund University: Lund, 2005.
19. Kazmierczak SC, Catrou PG, Van Lente F. Diagnostic accuracy of pancreatic enzymes evaluated by use of multivariate data analysis. Clin Chem 1993; 39: 1960-1965.
20. Pofahl WE, Walczak SM, Rhone E, Izenberg SD. Use of an artificial neural network to predict length of stay in acute pancreatitis. Am Surg 1998; 64: 868-872.
21. Keogan MT, Lo JY, Freed KS, Raptopoulos V, Blake S, Kamel IR et al. Outcome analysis of patients with acute pancreatitis by using an artificial neural network. Acad Radiol 2002; 9: 410-419.
22. Halonen KI, Leppaniemi AK, Lundin JE, Puolakkainen PA, Kemppainen EA, Haapiainen RK. Predicting fatal outcome in the early phase of severe acute pancreatitis by using novel prognostic models. Pancreatology 2003; 3: 309-315.
23. Mofidi R, Duff MD, Madhavan KK, Garden OJ, Parks RW. Identification of severe acute pancreatitis using an artificial neural network. Surgery 2007; 141: 59-66.
24. Spigset O, Hägg S, Bate A. Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitors: data from the World Health Organization (WHO) database of adverse drug reactions. Int Clin Psychopharmacol 2003; 18: 157-161.
25. Norton ID, Zheng Y, Wiersema MS, Greenleaf J, Clain JE, Dimagno EP. Neural network analysis of EUS images to differentiate between pancreatic malignancy and pancreatitis. Gastrointest Endosc 2001; 54: 625-629.
26. Ikeda M, Ito S, Ishigaki T, Yamauchi K. Evaluation of a neural network classifier for pancreatic masses based on CT findings. Comput Med Imaging Graph 1997; 21: 175-183.
27. Mattfeldt T, Gottfried H, Schmidt V, Kestler HA. Classification of spatial textures in benign and cancerous glandular tissues by stereology and stochastic geometry using artificial neural networks. J Microsc 2000; 198: 143-158.
28. Honda K, Hayashida Y, Umaki T, Okusaka T, Kosuge T, Kikuchi S et al. Possible detection of pancreatic cancer by plasma protein profiling. Cancer Res 2005; 65: 10613-10622.
29. Okoń K, Tomaszewska R, Nowak K, Stachura J. Application of neural networks to the classification of pancreatic intraductal proliferative lesions. Anal CellPathol 2001; 23: 129-136.
30. Bishop CM. Neural Networks for Pattern Recognition. Clarendon Press: Oxford, 1995.
31. Sarle WS. How to Measure Importance of Inputs? Revised 23 June 2000. ftp://ftp.sas.com/pub/neural/importance.html [accessed 23 June 2005].
32. Tu JV, Weinstein MC, McNeil BJ, Naylor CD. Predicting mortality after coronary artery bypass surgery: what do artificial neural networks learn? The Steering Committee of the Cardiac Care Network of Ontario. Med Decis Making 1998;18:229-235.
33. Lippmann RP, Shahian DM. Coronary artery bypass risk prediction using neural networks. Ann Thorac Surg 1997; 63: 1635-1643.
34. Burke HB, Goodman PH, Rosen DB, Henson DE, Weinstein JN, Harrell FE Jr et al. Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 1997; 79: 857-862.
35. Baxt WG. Application of artificial neural networks to clinical medicine. Lancet 1995; 346: 1135-1138.
36. Andersson B, Olin H, Eckerwall G, Andersson R. Severe acute pancreatitis - outcome following a primarily non-surgical regime. Pancreatology 2006; 6: 536-541.
37. British Society of Gastroenterology. United Kingdom guidelines for the management of acute pancreatitis. Gut 1998;42(Suppl2):S1-S13.
38. Sandberg ÅA, Borgstrom A. Early prediction of severity in acute pancreatitis. Is this possible? JOP 2002; 3: 116-125.
39. Smith RC, Southwell-Keely J, Chesher D. Should serum pancreatic lipase replace serum amylase as a biomarker of acute pancreatitis? ANZJ Surg 2005; 75: 399-404.
40. Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas 2000; 20: 367-372.
41. Neoptolemos JP, Kemppainen EA, Mayer JM, FitzpatrickJM, Raraty MGT, Slavin J et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-1960.
42. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-145.
43. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437.
44. Talamini G, Falconi M, Bassi C, Sartori N, Salvia R, Caldiron E et al. Incidence of cancer in the course of chronic pancreatitis. Am J Gastroenterol 1999; 94: 1253-1260.
45. Chen R, Rabinovitch PS, Crispin DA, Emond MJ, Bronner MP, Brentnall TA. The initiation of colon cancer in a chronic inflammatory setting. Carcinogenesis 2005; 26: 1513-1519.
46. Hall P de L, Wilentz R, De Klerk W, Bornman P. Premalignant conditions of the pancreas. Pathology 2002; 34: 504-517.
47. Klein AP, Brune KA, Petersen GM, Goggins M, Tersmette AC, Offerhaus GJ et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res 2004; 64: 2634-2638.
48. Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem 2005; 95: 649-656.
49. Vitone LJ, Greenhalf W, McFaul CD, Ghaneh P, Neoptolemos JP. The inherited genetics of pancreatic cancer and prospects for secondary screening. Best Pract Res Clin Gastroenterol 2006; 20: 253-283.
50. Bergman W, Watson P, de Jong J, Lynch HT, Fusaro RM. Systemic cancer and the FAMMM syndrome. Br J Cancer 1990;61:932-936.
51. Lynch HT, Fusaro RM. Pancreatic cancer and the familial atypical multiple melanoma (FAMMM) syndrome. Pancreas 1991; 6: 127-131.
52. Norell SE, Ahlbom A, Erwald R, Jacobson G, Lindberg-Navier I, Olin R et al. Diet and pancreatic cancer: a case-control study. Am J Epidemiol 1986; 124: 894-902.
53. Mills PK, Beeson L, Abbey DE, Fraser GE, Phillips RL. Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists. Cancer 1988; 61: 2578-2585.
54. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer 2007; 120: 1993-1998.
55. Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T. Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy. Cancer 2001; 91: 490-495.
56. Sezgin C, Karabulut B, Uslu R, Sanli UA, Goksel G, Yuzer Y et al. Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors. Scand J Gastroenterol 2005; 40: 1486-1492.
57. Terwee CB, Nieveen Van Dijkum EJ, Gouma DJ, Klinkenbijl JH, Wade TP et al. Pooling of prognostic studies in cancer of the pancreatic head and periampullary region: the Triple-P study. Triple-P Study Group. Eur J Surg 2000; 166: 706-712.
58. Ueno H, Okada S, Okusaka T, Ikeda M. Prognostic factors in patients with metastatic pancreatic adenocarcinomas receiving systemic chemotherapy. Oncology 2000; 59: 296-301.
59. Ghaneh P, Costello E, Neoptolemos J. Biology and management of pancreatic cancer. Gut 2007; 56: 1134-1152.
60. Ziske C, Schlie C, Gorschluter M, Glasmacher A, Mey U, Strehl J et al. Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine. Br J Cancer 2003; 89: 1413-1417.
61. Engelken FJ, Bettschart V, Rahman MQ, Parks RW, Garden OJ. Prognostic factors in the palliation of pancreatic cancer. EJSO 2003; 29: 368-373.
62. Niedergethmann M, Hildenbrand R, Wostbrock B, Hartel M, Stum J W, Richter A et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 2002; 25: 122-129.
63. Juuti A, Louhimo J, Nordling S, Ristimaki A, Haglund C. Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer. J Clin Pathol 2006; 59: 382-386.
64. Phoa SS, Tilleman EH, van Delden OM, Bossuyt PM, Gouma DJ, Laméris JS. Value of CT criteria in predicting survival in patients with potentially resectable pancreatic head carcinoma. J Surg Oncol 2005; 91: 33-40.